HIV-associated non-Hodgkin lymphoma of the oral cavity complicated by superinfection with a multidrug-resistant organism: a case report with a fatal outcome
DOI:
https://doi.org/10.20453/reh.v36i2.6462Keywords:
non-Hodgkin lymphoma, acquired immunodeficiency syndrome, odontogenic infections, oral cavity, case reportAbstract
Non-Hodgkin lymphoma of the oral cavity is uncommon and can mimic odontogenic infections, delaying early diagnosis, particularly in immunocompromised patients such as those with HIV infection. A 25-year-old male patient with a history of HIV infection not on antiretroviral therapy presented with severe pain in the right hemiface, trismus, and facial swelling. He reported a recent extraction of the lower right second molar (tooth 47), after which he developed a torpid course with progressive edema and functional limitation. Clinical examination revealed facial cellulitis and active periodontal lesions. Imaging studies, cultures, and an incisional biopsy of alveolar and bone tissue were performed. Histopathological and immunohistochemical analysis confirmed B-cell non-Hodgkin lymphoma. Staging was completed with colonoscopy, which identified an abdominal mass with systemic involvement. The patient was hospitalized and developed an infection caused by a multidrug-resistant organism. Antimicrobial treatment was initiated while specialized oncologic management was coordinated; however, he had a fatal outcome during hospitalization. This case highlights the importance of the dental provider's role in the early detection of atypical oral lesions that may initially mimic common odontogenic processes. Clinical evaluation and the decision to perform complementary studies, such as biopsy, were decisive in establishing the diagnosis of non-Hodgkin lymphoma. In untreated HIV-infected patients, timely dental care is key to guiding the differential diagnosis and improving prognosis.
Downloads
References
Kaplan LD. HIV-associated lymphoma. Best Pract Res Clin Haematol. 2012;25(1):101-17. doi:10.1016/j.beha.2012.01.001
Kaplan LD, Lee JY, Ambinder RF, et al. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 2005;106(5):1538-43. doi:10.1182/blood-2005-04-1437
Besson C, Lancar R, Prevot S, et al. Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era. AIDS. 2021;31(18):2493-2501. doi:10.1097/QAD.0000000000001652
Lomelí-Martínez SM, González-Hernández LA, Ruiz-Anaya AJ, et al. Oral manifestations associated with HIV/AIDS patients. Medicina. 2022;58(9):1214. doi:10.3390/medicina58091214
Glick M, editor. Burket’s Oral Medicine. Diagnosis and Treatment. 12th ed. Shelton (CT): People’s Medical Publishing House; 2019.
Bernal F. Farmacología de los antirretrovirales. Rev Med Clin Las Condes. 2016;27(5):682-97. doi:10.1016/j.rmclc.2016.09.013
Casariego Z, Micinquevich S, Laufer N, et al. Linfoma no Hodgkin oral relacionado al sida (LNHORS): actualización y presentación de un caso clínico. Av Odontoestomatol [Internet]. 2006;22(6):307-14. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-12852006000600002
Herrera-Rueda GA, Mogollón-Vargas JM, Serrano-García AY, et al. Linfomas en pacientes con VIH: una asociación compleja y frecuente. Revisión narrativa de la literatura. Med Lab. 2021;25(4):695-707. doi:10.36384/01232576.524
Martinelli-Kläy CP, Martinelli CR, Martinelli C, et al. Linfoma extranodal primario no Hodgkin en encía diagnosticado inicialmente de forma errónea como absceso dental. Quintessence [Internet]. 2011;24(3):161-4. Disponible en: https://www.elsevier.es/es-revista-quintessence-9-pdf-X0214098511013395
Vinitzky I, Traver V, Carrasco CA, et al. Linfoma no Hodgkin de células grandes «B» en cavidad oral: presentación de un caso y revisión de la literatura. Odontol Sanmarquina. 2020;23(2):181-8. doi:10.15381/os.v23i2.16910
Gutiérrez S, Navarro P, Donoso-Hofer F. Manifestación oral de linfoma linfoblástico de células-T: un caso inusual y desafiante. Rev Esp Cir Oral Maxilofac. 2023;45(2):83-7. doi:10.20986/recom.2023.1448/2023
Nápoles-González IJ, Álvarez-Rivero A, Santana-Álvarez J, et al. Atención estomatológica al paciente con cáncer bucal. Arch Med Camagüey [Internet]. 2022;26:e9044. Disponible: https://revistaamc.sld.cu/index.php/amc/article/view/9044
Bulboa C, Orellana R, Branera J, et al. Linfoma no Hodgkin primario extranodal de musculatura masticatoria. A propósito de un caso. Rev Otorrinolaringol Cir Cabeza Cuello. 2021;81(1):52-5. doi:10.4067/S0718-48162021000100052
Olvera-Acevedo A, Espinoza-Sánchez ML, Hurtado-Díaz J. Linfoma plasmablástico: reporte de un caso. Rev Méd Inst Mex Seguro Soc [Internet]. 2020;58(4):511-6. Disponible en: https://revistamedica.imss.gob.mx/index.php/revista_medica/article/view/2659
Salas MS, Caraciolo VB, de Matos L. Linfoma plasmablástico de cavidade oral em paciente sem infecção pelo vírus da imunodeficiência humana: relato de caso. Rev Bras Cancerol. 2024;70(2):e-174660. doi:10.32635/2176-9745.RBC.2024v70n2.4660
Martín H, Sánchez-Correa CA, Herrera-Méndez FM, et al. Compresión medular por linfoma B difuso de célula grande en columna torácica en paciente con infección por VIH no diagnosticada. Rev Colomb Ortop Traumatol. 2022;36(4):255-9. doi:10.1016/j.rccot.2022.10.001
Miranda E, Urbina I. VIH y linfoma no Hodgkin tipo B en una paciente con carga viral indetectable. Mediciencias UTA [Internet]. 2021;5(1):37-43. Disponible en: https://revistas.uta.edu.ec/erevista/index.php/medi/article/view/1100
Maldonado BE, Coyago JA, Maldonado JE, et al. Sobrevida de pacientes con diagnóstico de linfoma tipo Burkitt en portadores del virus de inmunodeficiencia humana. Salud Cienc Tecnol. 2022;2:179. doi:10.56294/saludcyt2022179
Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538-82. doi:10.1128/CMR.00058-07
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-10. doi:10.1001/jama.2016.0287
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181-247. doi:10.1007/s00134-021-06506-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Flor Milagros Mendoza Barreto, Roger Antonio Sernaque Mechato , Johan Raúl Valverde Mendoza , Rodolfo Valentino Ayre Estrada , Alexander Enrique Saldaña Arévalo, Sissi Oriana Masgo Malca , Maverick Vincent Herrera Morales, Silvana Rosario Steffanie Ñaupari Jara

This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the copyright and cede to the journal the right of first publication, with the work registered with the Creative Commons License, which allows third parties to use what is published as long as they mention the authorship of the work, and to the first publication in this journal.


















